New drug cocktails aim to shrink tumors before kidney cancer surgery
NCT ID NCT05148546
Summary
This study is testing three different combinations of immunotherapy drugs given to patients before surgery for intermediate-to-high-risk kidney cancer. The goal is to see which drug combination best shrinks the tumor and reduces the chance of the cancer coming back after surgery. About 69 patients will receive one of the three drug regimens for a few weeks before their planned operation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Netherlands Cancer Institute
Amsterdam, North Holland, 1066CX, Netherlands
-
Royal Free London NHS Foundation Trust
London, NW3 2QG, United Kingdom
Conditions
Explore the condition pages connected to this study.